Logo image of ALEC

ALECTOR INC (ALEC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALEC - US0144421072 - Common Stock

1.22 USD
0 (0%)
Last: 12/8/2025, 4:53:43 PM
1.22 USD
0 (0%)
After Hours: 12/8/2025, 4:53:43 PM
Fundamental Rating

2

ALEC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. Both the profitability and financial health of ALEC have multiple concerns. While showing a medium growth rate, ALEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALEC has reported negative net income.
ALEC had a negative operating cash flow in the past year.
In the past 5 years ALEC always reported negative net income.
In the past 5 years ALEC reported 4 times negative operating cash flow.
ALEC Yearly Net Income VS EBIT VS OCF VS FCFALEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a decent Return On Assets value of -32.13%, ALEC is doing good in the industry, outperforming 65.35% of the companies in the same industry.
ALEC has a Return On Equity of -186.68%. This is in the lower half of the industry: ALEC underperforms 67.80% of its industry peers.
Industry RankSector Rank
ROA -32.13%
ROE -186.68%
ROIC N/A
ROA(3y)-21.11%
ROA(5y)-21.34%
ROE(3y)-84.42%
ROE(5y)-67.29%
ROIC(3y)N/A
ROIC(5y)N/A
ALEC Yearly ROA, ROE, ROICALEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALEC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALEC Yearly Profit, Operating, Gross MarginsALEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

ALEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALEC has more shares outstanding
The number of shares outstanding for ALEC has been increased compared to 5 years ago.
ALEC has a worse debt/assets ratio than last year.
ALEC Yearly Shares OutstandingALEC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALEC Yearly Total Debt VS Total AssetsALEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ALEC has an Altman-Z score of -3.84. This is a bad value and indicates that ALEC is not financially healthy and even has some risk of bankruptcy.
ALEC has a Altman-Z score of -3.84. This is comparable to the rest of the industry: ALEC outperforms 41.24% of its industry peers.
ALEC has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ALEC's Debt to Equity ratio of 0.17 is on the low side compared to the rest of the industry. ALEC is outperformed by 66.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -3.84
ROIC/WACCN/A
WACC8.62%
ALEC Yearly LT Debt VS Equity VS FCFALEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

2.3 Liquidity

A Current Ratio of 3.76 indicates that ALEC has no problem at all paying its short term obligations.
ALEC has a Current ratio (3.76) which is in line with its industry peers.
A Quick Ratio of 3.76 indicates that ALEC has no problem at all paying its short term obligations.
ALEC's Quick ratio of 3.76 is in line compared to the rest of the industry. ALEC outperforms 46.70% of its industry peers.
Industry RankSector Rank
Current Ratio 3.76
Quick Ratio 3.76
ALEC Yearly Current Assets VS Current LiabilitesALEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

ALEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.06%, which is quite impressive.
Looking at the last year, ALEC shows a quite strong growth in Revenue. The Revenue has grown by 12.26% in the last year.
ALEC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.53% yearly.
EPS 1Y (TTM)37.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.93%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y-21.4%
Revenue growth 5Y36.53%
Sales Q2Q%-78.75%

3.2 Future

Based on estimates for the next years, ALEC will show a small growth in Earnings Per Share. The EPS will grow by 6.37% on average per year.
ALEC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.72% yearly.
EPS Next Y-21.55%
EPS Next 2Y1.2%
EPS Next 3Y-1.27%
EPS Next 5Y6.37%
Revenue Next Year-73.33%
Revenue Next 2Y-16.63%
Revenue Next 3Y-24.63%
Revenue Next 5Y-20.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALEC Yearly Revenue VS EstimatesALEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
ALEC Yearly EPS VS EstimatesALEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALEC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALEC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEC Price Earnings VS Forward Price EarningsALEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALEC Per share dataALEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.2%
EPS Next 3Y-1.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALEC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALECTOR INC

NASDAQ:ALEC (12/8/2025, 4:53:43 PM)

After market: 1.22 0 (0%)

1.22

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners82.38%
Inst Owner Change3.84%
Ins Owners6.63%
Ins Owner Change4.01%
Market Cap133.16M
Revenue(TTM)69.05M
Net Income(TTM)-107.74M
Analysts51.43
Price Target2.09 (71.31%)
Short Float %5.53%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.13%
Min EPS beat(2)18.2%
Max EPS beat(2)36.06%
EPS beat(4)4
Avg EPS beat(4)42.08%
Min EPS beat(4)17.12%
Max EPS beat(4)96.92%
EPS beat(8)8
Avg EPS beat(8)34.42%
EPS beat(12)11
Avg EPS beat(12)32.87%
EPS beat(16)12
Avg EPS beat(16)3.34%
Revenue beat(2)2
Avg Revenue beat(2)93.28%
Min Revenue beat(2)5.84%
Max Revenue beat(2)180.71%
Revenue beat(4)3
Avg Revenue beat(4)97.2%
Min Revenue beat(4)-17.7%
Max Revenue beat(4)219.92%
Revenue beat(8)6
Avg Revenue beat(8)55.89%
Revenue beat(12)8
Avg Revenue beat(12)123.78%
Revenue beat(16)9
Avg Revenue beat(16)90.6%
PT rev (1m)-6.82%
PT rev (3m)-46.52%
EPS NQ rev (1m)-1.87%
EPS NQ rev (3m)-8.26%
EPS NY rev (1m)5.23%
EPS NY rev (3m)4.75%
Revenue NQ rev (1m)11.76%
Revenue NQ rev (3m)-18.09%
Revenue NY rev (1m)2.51%
Revenue NY rev (3m)9.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.93
P/FCF N/A
P/OCF N/A
P/B 2.31
P/tB 2.31
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-1.81
OCFYN/A
SpS0.63
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.13%
ROE -186.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.11%
ROA(5y)-21.34%
ROE(3y)-84.42%
ROE(5y)-67.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.23%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.76
Quick Ratio 3.76
Altman-Z -3.84
F-Score3
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)45.58%
Cap/Depr(5y)54.45%
Cap/Sales(3y)2.26%
Cap/Sales(5y)6.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.93%
EPS Next Y-21.55%
EPS Next 2Y1.2%
EPS Next 3Y-1.27%
EPS Next 5Y6.37%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y-21.4%
Revenue growth 5Y36.53%
Sales Q2Q%-78.75%
Revenue Next Year-73.33%
Revenue Next 2Y-16.63%
Revenue Next 3Y-24.63%
Revenue Next 5Y-20.72%
EBIT growth 1Y32.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.81%
EBIT Next 3Y4.76%
EBIT Next 5Y9.32%
FCF growth 1Y-4.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.54%
OCF growth 3YN/A
OCF growth 5YN/A

ALECTOR INC / ALEC FAQ

What is the ChartMill fundamental rating of ALECTOR INC (ALEC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEC.


What is the valuation status for ALEC stock?

ChartMill assigns a valuation rating of 0 / 10 to ALECTOR INC (ALEC). This can be considered as Overvalued.


What is the profitability of ALEC stock?

ALECTOR INC (ALEC) has a profitability rating of 1 / 10.


What is the expected EPS growth for ALECTOR INC (ALEC) stock?

The Earnings per Share (EPS) of ALECTOR INC (ALEC) is expected to decline by -21.55% in the next year.